Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies.
Breast cancer remains a significant challenge in oncology, highlighting the need for alternative therapeutic strategies that target necroptosis to overcome resistance to conventional therapies. Recent investigations into natural compounds have identified 8,12-dimethoxysanguinarine (SG-A) from Eomeco...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0313094 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841533164492685312 |
|---|---|
| author | Maram B Alhawarri Mohammad G Al-Thiabat Amit Dubey Aisha Tufail Katreen Banisalman Ghazi A Al Jabal Eman Alkasasbeh Esra'a Ibrahim Al-Trad Bilal Harieth Alrimawi |
| author_facet | Maram B Alhawarri Mohammad G Al-Thiabat Amit Dubey Aisha Tufail Katreen Banisalman Ghazi A Al Jabal Eman Alkasasbeh Esra'a Ibrahim Al-Trad Bilal Harieth Alrimawi |
| author_sort | Maram B Alhawarri |
| collection | DOAJ |
| description | Breast cancer remains a significant challenge in oncology, highlighting the need for alternative therapeutic strategies that target necroptosis to overcome resistance to conventional therapies. Recent investigations into natural compounds have identified 8,12-dimethoxysanguinarine (SG-A) from Eomecon chionantha as a potential necroptosis inducer. This study presents the first computational exploration of SG-A interactions with key necroptotic proteins-RIPK1, RIPK3, and MLKL-through molecular docking, molecular dynamics (MD), density functional theory (DFT), and molecular electrostatic potential (MEP) analyses. Molecular docking revealed that SG-A exhibited a stronger affinity for MLKL (-9.40 kcal/mol) compared to the co-crystallized ligand (-6.29 kcal/mol), while its affinity for RIPK1 (-6.37 kcal/mol) and RIPK3 (-7.01 kcal/mol) was lower. MD simulations further demonstrated the stability of SG-A within the MLKL site, with RMSD values stabilizing between 1.4 and 3.3 Å over 300 ns, indicating a consistent interaction pattern. RMSF analysis indicated the preservation of protein backbone flexibility, with average fluctuations under 1.7 Å. The radius of gyration (Rg) results indicated a consistent value of ~15.3 Å across systems, confirming the role of SG-A in maintaining protein integrity. Notably, SG-A maintains two critical H-bonds within the active site of MLKL, reinforcing the stability of the interaction. Principal component analysis (PCA) indicated a significant reduction in MLKL's conformational space upon SG-A binding, implying enhanced stabilization. Dynamic cross-correlation map (DCCM) analysis further revealed that SG-A induced highly correlated motions, reducing internal fluctuations within MLKL compared to the co-crystallized ligand. MM-PBSA revealed the enhanced binding efficacy of SG-A, with a significant binding free energy of -31.03 ± 0.16 kcal/mol against MLKL, surpassing that of the control (23.96 ± 0.11 kcal/mol). In addition, the individual residue contribution analysis highlighted key interactions, with ARG149 showing a significant contribution (-176.24 kcal/mol) in the MLKL-SG-A complex. DFT and MEP studies corroborated these findings, revealing that the electronic structure of SG-A is conducive to stable binding interactions, characterized by a narrow band gap (~0.16 units) and distinct electrostatic potential favourable for necroptosis induction. In conclusion, SG-A has emerged as a compelling inducer of necroptosis for breast cancer therapy, warranting further experimental validation to fully realize its therapeutic potential. |
| format | Article |
| id | doaj-art-667ab154876e45b28543b65cae5fe622 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-667ab154876e45b28543b65cae5fe6222025-01-17T05:31:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031309410.1371/journal.pone.0313094Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies.Maram B AlhawarriMohammad G Al-ThiabatAmit DubeyAisha TufailKatreen BanisalmanGhazi A Al JabalEman AlkasasbehEsra'a Ibrahim Al-TradBilal Harieth AlrimawiBreast cancer remains a significant challenge in oncology, highlighting the need for alternative therapeutic strategies that target necroptosis to overcome resistance to conventional therapies. Recent investigations into natural compounds have identified 8,12-dimethoxysanguinarine (SG-A) from Eomecon chionantha as a potential necroptosis inducer. This study presents the first computational exploration of SG-A interactions with key necroptotic proteins-RIPK1, RIPK3, and MLKL-through molecular docking, molecular dynamics (MD), density functional theory (DFT), and molecular electrostatic potential (MEP) analyses. Molecular docking revealed that SG-A exhibited a stronger affinity for MLKL (-9.40 kcal/mol) compared to the co-crystallized ligand (-6.29 kcal/mol), while its affinity for RIPK1 (-6.37 kcal/mol) and RIPK3 (-7.01 kcal/mol) was lower. MD simulations further demonstrated the stability of SG-A within the MLKL site, with RMSD values stabilizing between 1.4 and 3.3 Å over 300 ns, indicating a consistent interaction pattern. RMSF analysis indicated the preservation of protein backbone flexibility, with average fluctuations under 1.7 Å. The radius of gyration (Rg) results indicated a consistent value of ~15.3 Å across systems, confirming the role of SG-A in maintaining protein integrity. Notably, SG-A maintains two critical H-bonds within the active site of MLKL, reinforcing the stability of the interaction. Principal component analysis (PCA) indicated a significant reduction in MLKL's conformational space upon SG-A binding, implying enhanced stabilization. Dynamic cross-correlation map (DCCM) analysis further revealed that SG-A induced highly correlated motions, reducing internal fluctuations within MLKL compared to the co-crystallized ligand. MM-PBSA revealed the enhanced binding efficacy of SG-A, with a significant binding free energy of -31.03 ± 0.16 kcal/mol against MLKL, surpassing that of the control (23.96 ± 0.11 kcal/mol). In addition, the individual residue contribution analysis highlighted key interactions, with ARG149 showing a significant contribution (-176.24 kcal/mol) in the MLKL-SG-A complex. DFT and MEP studies corroborated these findings, revealing that the electronic structure of SG-A is conducive to stable binding interactions, characterized by a narrow band gap (~0.16 units) and distinct electrostatic potential favourable for necroptosis induction. In conclusion, SG-A has emerged as a compelling inducer of necroptosis for breast cancer therapy, warranting further experimental validation to fully realize its therapeutic potential.https://doi.org/10.1371/journal.pone.0313094 |
| spellingShingle | Maram B Alhawarri Mohammad G Al-Thiabat Amit Dubey Aisha Tufail Katreen Banisalman Ghazi A Al Jabal Eman Alkasasbeh Esra'a Ibrahim Al-Trad Bilal Harieth Alrimawi Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies. PLoS ONE |
| title | Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies. |
| title_full | Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies. |
| title_fullStr | Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies. |
| title_full_unstemmed | Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies. |
| title_short | Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies. |
| title_sort | targeting necroptosis in mcf 7 breast cancer cells in silico insights into 8 12 dimethoxysanguinarine from eomecon chionantha through molecular docking dynamics dft and mep studies |
| url | https://doi.org/10.1371/journal.pone.0313094 |
| work_keys_str_mv | AT marambalhawarri targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT mohammadgalthiabat targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT amitdubey targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT aishatufail targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT katreenbanisalman targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT ghaziaaljabal targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT emanalkasasbeh targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT esraaibrahimaltrad targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies AT bilalhariethalrimawi targetingnecroptosisinmcf7breastcancercellsinsilicoinsightsinto812dimethoxysanguinarinefromeomeconchionanthathroughmoleculardockingdynamicsdftandmepstudies |